Regulatory Considerations of Pharmaceutical Impurities with Emphasis on Genotoxic Impurities
Регуляторные аспекты примесей в фармацевтических препаратах с акцентом на генотоксичные примеси
2024-01-01
SCID: 54.1/65369dvd
Discuss with AI
elemental contaminantsgenotoxic impuritiespharmaceutical impurity profilingregulatory requirementsresidual solvents
Figures from the paper
Abstract (AI)
Over the past decade, significant changes have occurred in the approach to drug impurity profiling, as reflected in pharmacopeial and regulatory standards. This review provides an in-depth exploration of impurity profiling, focusing on the regulatory requirements. It offers detailed insights into various impurities such as residual solvents, water impurities, elemental contaminants, and carcinogenic substances, with special attention to genotoxic impurities. To meet the required quality standard
Key Findings
1
Genotoxic impurities receive particular emphasis because of their regulatory and safety significance.
2
It addresses residual solvents, water impurities, elemental contaminants, and carcinogenic substances as important impurity categories.
3
Pharmaceutical impurity profiling approaches and regulatory standards have undergone substantial changes over the past decade.
4
The review examines regulatory requirements governing pharmaceutical impurities and impurity profiling.
5
The review highlights the need to meet established quality standards for pharmaceutical products.
Research Object
pharmaceutical impurities in drug products
Research Subject
regulatory requirements and impurity-profiling considerations, with emphasis on genotoxic impurities
Publication Details
Publication Date
2024-01-01
Journal
Publisher
ISSN
Cited by
23
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest